Editorial
|
|
|
|
|
Health professionals cannot put their trust in regulators
|
|
|
|
New Products
|
|
|
|
|
Longer follow-up confirms the overall survival benefit
|
|
|
|
|
|
|
|
|
|
Kidney cancer: many risks, but is there a benefit for patients?
|
|
|
|
|
|
|
|
|
|
|
|
A 3-drug fixed-dose combination for hypertension: too many drawbacks
|
|
|
|
|
|
Adverse Effects
|
|
|
|
|
Potentially severe reactions
|
|
|
|
|
|
|
|
|
|
A useful complement to reports by health professionals
|
|
|
|
|
|
|
|
|
|
|
|
Several convincing experiments
|
|
|
|
Reviews
|
|
|
|
|
Intrapartum antibiotic prophylaxis in some high-risk situations
|
|
|
|
|
|
|
|
|
|
|
|
Targeting below 120 mmHg is no better
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|